GCAM, Inc. (GCAM) is dedicated to and specializes in the plasma industry. Our facilities are licensed and regulated by the Food and Drug Administration (FDA), and both Federal and State agencies routinely inspect the centers.
GCAM operates multiple plasma collection centers across the United States. Annually we produce approximately 100,000 liters of plasma that meet FDA facilities and quality standards and in turn supply this to Green Cross.
Green Cross is a biopharmaceutical company headquartered in Yongin, South Korea. They specialize in the development and commercialization of vaccines, plasma-derivatives, recombinant proteins, and therapeutic antibodies for use in the fields of oncology and infectious disease. GCAM was established to secure a stable supply of plasma as raw material for plasma fractionation products and enter the U.S. market according to the global strategy of Green Cross.